SINDROM HIPERSENSITIVITAS DAPSON PADA PASIEN MORBUS HANSEN MULTI-BASILER: LAPORAN KASUS

  • Fitri Kadarsih Bandjar Fakultas Kedokteran Universitas Pattimura
Keywords: Keywords: dapsone hipersensitivity syndrome, multibacillary leprosy, corticosteroids

Abstract

Dapsone syndrome is a syndrome that occurs after dapsone therapy within a period of 48 hours to 6 months after dapsone use and does not depend on the drug dose. The clinical manifestations can resemble other drug allergies and have a fatal risk if not treated properly.The classic triad of dapsone syndrome consists of fever, internal organ involvement and skin eruption/exfoliative dermatitis. The diagnosis of dapsone hypersensitivity syndrome is made if a hypersensitivity reaction occurs after dapsone therapy for 2-8 weeks followed by two of the following symptoms: fever, skin eruption, lymphadenopathy, and impaired liver function. Treatment of dapsone hypersensitivity syndrome is to immediately stop the dapsone drug and administer adequate corticosteroids. We report the case of a 19-year-old male diagnosed with multibacillary leprosy and receiving multidrug therapy-multibacillary (MDT-MB) therapy for the second month. Six weeks after starting therapy, fever, bumps and sores appeared almost all over the body accompanied by yellow eyes. On physical examination, hyperpigmented macules, nodules, ulcers, anemic conjunctiva and icteric sclera were found. Laboratory examination revealed anemia, leukocytosis, and increased liver enzymes. Based on clinical findings and supporting examinations, a diagnosis of dapsone hypersensitivity syndrome was made. After starting dapsone and administering desoxymethasone 5 mg per 24 hours intravenously, then tapered, clinical and laboratory findings showed improvement.

Downloads

Download data is not yet available.

References

Lee J, An HK, Sohn M, Kivela P, Oh S. 4,4-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor. Int J Mol Sci. 2020;21(5953):2–3.

Bolognia JL, Schaffer J V, Cerroni L. Medical Therapy: Other Systemic Drugs. In: Callen JP, Cowen EW, Hruza G, Jorizzo JL, Lui H, Requena L, et al., editors. Dermatology. 4th ed. China: Elsevier; 2018. p. 2288–9.

Lockwood DNJ. Leprosy. In: Griffiths C, Barker J, Bleiker T, Chalmers R, editors. Rook’s Textbook of Dermatology. 9th ed. UK: Wiley Blackwell; 2016. p. 1913–5.

Kesari HV, Gawali UP, Agharia MAM. Dapsone hipersensitivity syndrome: a potentially fatal condition - case report. J Clin Diag Res. 2017;11(12):FD01- FD03.

Kusumastanto VA, Esti PK. Laporan kasus sindrom dapson pada pasien morbus hansen. CDK-225;2015; 42 (2): 123-5.

Alungal J, Abdulla MC, Kunnummal NK, Sivadasan A. Dapson induced hypersensitivity syndrome, hemolytic anemia and sever agranulocytosis. Internasional Journal of Nutrition Pharmacology. Neurological Diseases. 2015;5:113-6

Goh CL, Pan JY. Dapsone. In: Fitzpatrick’s Dermatology. 9th ed. United States: Mc Graw Hill Education; 2019. p. 3423–9.

Gunturu LN, Sunaina V, Santhosh R, Kiran H. Dapsone Hypersensitivity Syndrome: a Complication of Dapsone Therapy. Innovare J Med Sci. 2021;9(2):7–8.

Kumar B, Kar HK, editors. Therapeutics (Medical and Surgical), Prophylaxis and Vaccines. In: IAL Textbook of Leprosy. second. New Delhi: Jaype Brothers Medical Publisher; 2016. p. 442.

Hartanto F, Esti PK. Elevation of Transaminase Enzyme Levels in Leprosy. Media Dermato-Venerologica Indones. 2019;46(3):116–66.

Goh CL, Pan JY. Dapsone. In: Fitzpatrick’s Dermatology. 9th ed. United States: Mc Graw Hill Education; 2019. p. 3423–9.

Kar KH, Chauhan A. Leprosy Reaction: Pathogenesis and Clinical Features. In: Kumar B, Kar H, editors. IAL Textbook of Leprosy. 2nd ed. New Delhi: The Health Sciences Publisher; 2017. p. 416–34.

Halim KC, Aisyah PB, Tan ST. Neurotropic ulcer on Morbus Hansen multibacillary type Morbus patient : A challenging case to detect Neurotropic ulcer on Morbus Hansen multibacillary type Morbus patient : A challenging case to detect. 2020;(September):3–6.

Fernandes T, Lopes R, Santos T. Leg ulcer in lepromatous leprosy - Case report. An Bras Dermatol. 2017;91(5):673–5.

Published
2024-04-28
How to Cite
1.
Bandjar F. SINDROM HIPERSENSITIVITAS DAPSON PADA PASIEN MORBUS HANSEN MULTI-BASILER: LAPORAN KASUS. PAMERI [Internet]. 28Apr.2024 [cited 13May2024];6(1):1-. Available from: https://ojs3.unpatti.ac.id/index.php/pameri/article/view/12348

Most read articles by the same author(s)